Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Business Wire

Business Wire

Business Wire is the global leader in news release distribution and regulatory disclosure. Business Wire delivers news and multimedia directly into editorial systems and leading online news platforms and is a trusted source for news organisations, journalists, investment professionals and regulatory authorities.

Results: 133-144 of 21054

Business Wire logo

TVS Motor Company Ranked #1 Globally For Shareholder Value Creation In ‘Durable Consumer Goods’ By WirtschaftsWoche And Boston Consulting Group

Left to right are ePass co-founders James Buchan (CEO) and Chris Renga (CTO)

ePass Aims to Be Scotland’s Top GovTech Scaleup After Reporting £1M Revenue in First Year

Business Wire associated0

Barilla Opens Global Call for Startups Through Good Food Makers 2026

LazEdge Laser SEM system

JEOL: Sales Launch of the Laser SEM System “LazEdge”

Business Wire logo

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch

Adam Plich, CEO and Co-Founder of Avanzanite Bioscience.

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia

Business Wire logo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX

Business Wire logo

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors

Business Wire logo

AI & Tech Sandbox Unveils Cannes Lions 2026 Programming Focused on Learning, Discovery, and What’s Next in AI

Business Wire associated0

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly

Business Wire logo

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 2026

  • Prev Page
  • 1
  • 2
  • …
  • 11
  • 12
  • 13
  • …
  • 1754
  • 1755
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us